The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts-Reference-Cited by-同舟云学术

The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts

Published:2018-08-20 Issue:4 Volume:54 Page:567-577
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Liu Jing,Ma Rui,Liu Yan-Rong,Xu Lan-Ping,Zhang Xiao-Hui,Chen Huan,Chen Yu-Hong,Wang Feng-Rong,Han Wei,Sun Yu-Qian,Yan Chen-Hua,Tang Fei-Fei,Mo Xiao-Dong,Liu Kai-Yan,Fan Qiao-Zhen,Huang Xiao-Jun,Chang Ying-Jun

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0300-8.pdf

Reference26 articles.

1. Campana D, Leung W. Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation. Br J Haematol. 2013;162:147–61. https://doi.org/10.1111/bjh.12358

2. Buckley SA, Appelbaum FR, Walter RB. Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia. Bone Marrow Transplant. 2013;48:630–41. https://doi.org/10.1038/bmt.2012.139

3. Hourigan CS, Karp JE. Minimal residual disease in acute myeloid leukaemia. Nat Rev Clin Oncol. 2013;10:460–71. https://doi.org/10.1038/nrclinonc.2013.100

4. Freeman SD, Virgo P, Couzens S, Grimwade D, Russell N, Hills RK, et al. Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia. J Clin Oncol. 2013;31:4123–31. https://doi.org/10.1200/JCO.2013.49.1753

5. Walter RB, Gyurkocza B, Storer BE, Godwin CD, Pagel JM, Buckley SA, et al. Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation. Leukemia. 2015;29:137–44. https://doi.org/10.1038/leu.2014.173

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia Patients;Clinical Transplantation;2024-07

2. MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study;Blood Cancer Journal;2024-01-17

3. Monitoring Measurable/Minimal Residual Disease in Acute Myeloid Leukemia: Multiparametric Flow Cytometry-Based Approach;Indian Journal of Medical and Paediatric Oncology;2023-11-27

4. Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them;Expert Review of Hematology;2023-11-21

5. Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China;Bone Marrow Transplantation;2023-09-20